Kiora Pharmaceuticals Inc. logo

Kiora Pharmaceuticals Inc.

KPRX | NASDAQ
Chart Builder DCF Calculator
$2.68
-$0.08 (-2.90%)
At close: Sep 21, 2026, 4:00 PM ET
$2.65
-$0.03 (-1.12%)
Pre-market: Sep 22, 2026, 7:37 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-10.84M 3.59M -12.51M -13.58M -13.77M -6.86M
Depreciation & Amortization
24.8K 19.21K 51.8K 41.61K 45.3K 33.4K
Stock-Based Compensation
900.24K 656.59K 754.94K 462.45K 842.48K 723.86K
Other Working Capital
-1.98M 2.41M -465.83K 758.79K -283.94K -438.95K
Other Non-Cash Items
3.61M 911.27K 3.88M 2.1M 3.44M -903.5K
Deferred Income Tax
-388.54K -288.75K 90.32K -113.01K -192.6K 12.06K
Change in Working Capital
-3.27M 3.67M -1.82M 668.51K -1.04M -321.21K
Operating Cash Flow
-9.96M 8.56M -9.56M -10.43M -10.68M -7.32M
Capital Expenditures
-110.79K -6.26K n/a n/a -63.87K -20.08K
Cash Acquisitions
n/a n/a n/a n/a -93.16K -224.36K
Purchase of Investments
-8.18M -35.63M n/a n/a n/a n/a
Sales Maturities Of Investments
22.71M 12.98M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 6.38K n/a n/a
Investing Cash Flow
14.43M -22.66M n/a 6.38K -157.02K -244.44K
Debt Repayment
n/a n/a n/a n/a -212.28K 278.19K
Common Stock Repurchased
n/a n/a n/a -15.63K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 499.29K -1M 3.26M 50K -280.69K
Financial Cash Flow
265.66K 15.5M 5.97M 8.62M 17.58M 5M
Net Cash Flow
4.9M 1.34M -3.55M -1.89M 6.67M -2.59M
Free Cash Flow
-10.07M 8.55M -9.56M -10.43M -10.74M -7.34M
Adj. Free Cash Flow
-10.97M 7.9M -10.31M -10.89M -11.58M -8.06M
Maintenance CapEx
-110.79K n/a n/a n/a -63.87K -20.08K
Growth CapEx
n/a -6.26K n/a n/a n/a n/a
Owner Earnings
-10.07M 8.56M -9.56M -10.43M -10.74M -7.34M

© 2026 bestshares.com. All rights reserved.